Business
DNA Brands to Enter the Exploding Medical Marijuana/ CBD/ Industrial Hemp Markets
DNA Brands to Enter the Exploding Medical Marijuana/ CBD/ Industrial Hemp Markets.
About this update from Dna Brands, Inc.
[{"type":"text","content":"\n \n \n DNA Brands to Enter the Exploding Medical Marijuana/ CBD/ Industrial Hemp Markets\n \n \nDNA Brands to Enter the Exploding Medical Marijuana/ CBD/ Industrial Hemp Markets\n \n FT. LAUDERDALE, FL--(Marketwired - May 15, 2017) - DNA Brands Inc. (OTC PINK: DNAX) is pleased to announce today that it will be pursuing the CBD/MMJ/ Industrial Hemp marketplace after CEO Adrian McKenzie recently returned from Colorado. DNA Brands will concentrate on ancillary businesses in that sector, which are the backbone of the industry. DNA Brands looks to build both a worldwide online presence, while maintaining a physical presence on both the Northeastern and Southeastern Coasts. The sector, while still in its infancy, has a huge upside potential for future growth.\n As this market is constantly changing, even this past week Vermont has become one of the first few states to pass a recreational marijuana legalization bill through its legislature. \n http://thehill.com/homenews/state-watch/332803-vermont-legislature-approves-recreational-marijuana-use\n Until recently, management has been attempting to relaunch production of its two-time award winning energy drink line. After recently going through the corrosive testing process, as well as talking with distributors throughout the industry and majority shareholders, the company has decided to cease all intent of energy drink production and enter the MMJ/ CBD/ Industrial Hemp Arena.\n CEO Adrian McKenzie recently met with company council in Denver Colorado, while reviewing and evaluating many different business opportunities in the MMJ/CBD/ Industrial HEMP marketplace.\n DNA Brands Inc. still owns the two-time award winning line of flavored energy drinks, and will consider private labeling the drinks if the interest presents itself. However, after many meetings and discussions with management and the majority shareholders, at this point in time, the majority shareholders are only prepared to allocate funds in a less capital intensive market, that has a much quicker turnaround time on deployed capital (i.e. revenue and cash-flowing). We are all in agreement that the beverage market is very capital intensive, where the turnaround time on deployed capital would be better served elsewhere. \n In addition, only if financing allows for it, management will consider a CBD-inf...